Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.955 SEK | +2.20% | +2.99% | +27.99% |
04-08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
04-04 | OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge | CI |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stian Kildal
CEO | Chief Executive Officer | - | 23-09-12 |
Michael Owens
DFI | Director of Finance/CFO | 68 | 23-10-11 |
Markus Jerling
CTO | Chief Tech/Sci/R&D Officer | 72 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christoph Nowak
BRD | Director/Board Member | 38 | 23-09-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,713,244 | 3,978,430 ( 33.97 %) | 0 | 33.97 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.99% | 4.27M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- ONCOZ Stock
- Company OncoZenge AB